HIV-positive pregnant and postpartum women's perspectives about Option B+ in Malawi: A qualitative study

Journal of the International AIDS Society

Volumn 19, Issue 1, 2016, Pages

  Katirayi, Leila ^a   Namadingo, Hazel ^a   Phiri, Mafayo ^a   Bobrow, Emily A ^a   Ahimbisibwe, Allan ^a   Berhan, Aida Yemane ^a   Buono, Nicole ^a   Moland, Karen Marie ^b   Tylleskär, Thorkild ^b  

^a ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION   (United States)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Counselling; Lifelong HIV treatment; Option B+; Prevention of mother to child transmission of HIV; Qualitative; Same day initiation

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ANTIVIRAL RESISTANCE; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HEALTH CARE PERSONNEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MALAWI; MIDDLE AGED; PATIENT COUNSELING; PRACTICE GUIDELINE; PREGNANT WOMAN; PRENATAL CARE; PRIORITY JOURNAL; PUERPERIUM; QUALITATIVE RESEARCH; VERTICAL TRANSMISSION; VIRUS TRANSMISSION; BREAST FEEDING; COUNSELING; EPIDEMIOLOGY; HIV INFECTIONS; INFORMATION PROCESSING; NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVENTION AND CONTROL;

ADULT; ANTI-HIV AGENTS; BREAST FEEDING; CD4 LYMPHOCYTE COUNT; COUNSELING; FEMALE; FOCUS GROUPS; HEALTH PERSONNEL; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALAWI; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; QUALITATIVE RESEARCH;

EID: 84975886249     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.7448/IAS.19.1.20919     Document Type: Article

References (15)

1. Van Lettow M, Bedell R, Mayuni I, Mateyu G, Landes M, Chan AK, et al. Towards elimination of mother-to-child transmission of HIV: performance of different models of care for initiating lifelong antiretroviral therapy for pregnant women in Malawi (Option B+). J Int AIDS Soc. 2014;17(1):18994.
2. The World Health Organization (WHO). Implementation of Option B+ for prevention of mother-to-child transmission of HIV: the Malawi experience [Internet]. 2014. [cited 2015 Dec 8]. Available from: http://www.zero-hiv.org/wp-content/uploads/2014/04/Implementation-of-Option-B+-for-prevention-of-mother-to-child-transmissi....pdf
3. The Centers for Disease Control and Prevention (CDC). Impact of an innovative approach to prevent mother-to-child transmission of HIV - Malawi, July 2011-September 2012. Morb Mortal Wkly Rep. 2013;62(8):148-51.
4. Tenthani L, Haas AD, Tweya H, Jahn A, van Oosterhout JJ, Chimbwandira F, et al. Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women ("Option B+") in Malawi. AIDS. 2014;28(4):589-98.
5. Tweya H, Gugsa S, Hosseinipour M, Speight C, Ng'ambi W, Bokosi M, et al. Understanding factors, outcomes and reasons for loss to follow-up among women in Option B+ PMTCT programme in Malawi. Trop Med Int Health. 2014;19(11):136-06.
6. Rollins N, Chanza H, Chimbwandira F, Eliya M, Nyasulu I, Thom E, et al. Prioritizing the PMTCT implementation research agenda in 3 African countries: integrating and scaling up PMTCT through implementation research (INSPIRE). J Acquir Immune Defic Syndr. 2014;67(Suppl 2):S108-13.
7. Vaismoradi M, Turunen H, Bondas T. Content analysis and thematic analysis: implications for conducting a qualitative descriptive study. Nurs Health Sci. 2013;15(3):398-405.
8. Curran K, Ngure K, Shell-Duncan B, Vusha S, Mugo NR, Heffron R, et al. "If I am given antiretrovirals I will think I am nearing the grave": Kenyan HIV serodiscordant couples' attitudes regarding early initiation of antiretroviral therapy. AIDS. 2014;28(2):227-33.
9. Finkelstein JL, Gala P, Rochford R, Glesby MJ, Mehta S. HIV/AIDS and lipodystrophy: implications for clinical management in resource-limited settings. J Int AIDS Soc. 2015;18(1):19033.
10. Ngarina M, Tarimo EA, Naburi H, Kilewo C, Mwanyika-Sando M, Chalamilla G, et al. Women's preferences regarding infant or maternal antiretroviral prophylaxis for prevention of mother to child transmission of HIV during breastfeeding and their views on Option B+ in Dar es Salaam, Tanzania. PLoS One. 2014;9(1):e85310.
11. Kasenga F, Hurtig AK, Emmelin M. HIV-positive women's experiences of a PMTCT programme in rural Malawi. Midwifery. 2010;26(1):27-37.
12. Kim MH, Ahmed S, Hosseinipour MC, Giordano TP, Chiao EY, Yu X, et al. Implementation and operational research: the impact of Option B+ on the Antenatal PMTCT cascade in Lilongwe, Malawi. J Acquir Immune Defic Syndr. 2015;68(5):77-e83.
13. Webb R, Cullel M (Rebekah Webb Consulting). Understanding the perspectives and/or experiences of women living with HIV regarding Option B+ in Uganda and Malawi. Final Report. Rebekah Webb Consulting; 2013. [cited 2015 Nov 11]. Available from: http://www.gnpplus.net/assets/2013-Option-B+-Report-GNP-and-ICW.pdf
14. Colombini M, Stöckl H, Watts C, Zimmerman C, Agamasu E, Mayhew SH. Factors affecting adherence to short-course ARV prophylaxis for preventing mother-to-child transmission of HIV in sub-Saharan Africa: a review and lessons for future elimination. AIDS Care. 2014;26(7):914-26.
15. Kieffer MP, Mattingly M, Giphart A, van de Ven R, Chouraya C, Walakira M, et al. Lessons learned from early implementation of Option B+: the Elizabeth Glaser pediatric AIDS foundation experience in 11 African countries. Acquir Immune Defic Syndr. 2014;67(Suppl 4):S188-94.